Non-diabetics use Ozempic (semaglutide) primarily off-label for significant weight loss, due to its appetite-reducing effects and ability to promote fullness, but also for cardiovascular risk reduction in obese/overweight individuals with existing heart disease, with research also exploring benefits for addiction, brain health, and fatty liver disease, though shortages and potential long-term risks, especially from off-label use, are concerns, with Wegovy being the FDA-approved version for weight management.
Still, the FDA has not yet granted full approval for tirzepatide as a weight-loss drug for non-diabetics. For now, its use in that context is considered “off-label,” meaning doctors can prescribe it based on their own clinical judgment.
Ozempic is an injectable medication that helps to lower blood sugar levels in people with type 2 diabetes. Some rare side effects of Ozempic can cause fluid build-up in the legs, which may feel similar to joint pain. No confirmed cases of joint pain are associated with Ozempic.
Tricyclic antidepressants (TCAs) such as amitriptyline are associated with weight gain and potential insulin resistance, which may counteract the glucose-lowering effects of Ozempic.
Ozempic, known generically as semaglutide, was approved in 2017 by the U.S. Food and Drug Administration (FDA) for use in adults with type 2 diabetes. Ozempic is a weekly injection that helps lower blood sugar by helping the pancreas make more insulin.
One possible mechanism leading to “Ozempic face” is the rapid loss of fat, which can alter the proportions of the face, resulting in facial aging. “Ozempic face” is not a side effect exclusively linked with semaglutide or other GLP-1RA, but an outcome of rapid weight loss and malnutrition.
But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year. Studies suggest that most people discontinue their use due to the high cost and adverse gastrointestinal side-effects.
Medical Contraindications for Ozempic
Some examples of long-term side effects you may experience from Ozempic include pancreatitis, vision problems, kidney injury, and skin changes (e.g., Ozempic face).
Some possible interactions of Ozempic include other diabetes treatments, like insulin and oral medications, antimalarials, anticoagulants, digoxin, phenytoin, certain antibiotics, and blood pressure medications.
'Ozempic legs' is an informal term describing visible changes in leg appearance—such as reduced fat volume, increased muscle and vein visibility, and looser skin—that some people experience during treatment with semaglutide (Ozempic) or similar GLP-1 receptor agonists.
Key Points. Acute pain in multiple joints is most often due to inflammation, gout, or the beginning or flare up of a chronic joint disorder. Chronic pain in multiple joints is usually due to osteoarthritis or an inflammatory disorder (such as rheumatoid arthritis) or, in children, juvenile idiopathic arthritis.
Yes, gently pinching a fold of skin helps ensure the needle goes into the fatty tissue underneath, not into muscle. Here's how to do it: Use your thumb and forefinger to lift a small fold of skin at your injection site. Insert the needle straight into this fold at a 90-degree angle.
"Ozempic face" as a side effect of GLP-1 drugs
Non-diabetic patients prescribed semaglutide have an increased likelihood of delayed gastric emptying and gallstones compared to those on other weight loss medications.
Discover the Brazilian Mounjaro drink—a simple yet powerful fat-burning elixir made with butterfly pea flower, apple cider vinegar, lemon juice, honey, and ginger.
No, Ozempic hasn't been shown to affect lifespan, but no studies have directly measured its impact on lifespan.
What is the most important information I should know about Ozempic®? Ozempic® may cause serious side effects, including: Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
The researchers found that people using it had an increased risk of gastrointestinal conditions (like nausea and vomiting), abdominal pain, low blood pressure and arthritis. Surprisingly, the researchers also uncovered an increased risk of uncommon, yet serious, pancreas and kidney conditions.
It's unusual, but Ozempic can paralyze the stomach – a condition called gastroparesis. The muscle contractions in the stomach become so weak that the stomach can't digest food and push it forward into the intestines. This can result in food sitting in the stomach for too long.
"Ozempic hands" is a slang term for the skeletal or aged appearance hands can develop due to rapid fat loss from medications like Ozempic (semaglutide), where thinner skin reveals more prominent veins, tendons, and bones, resulting in a loss of fullness. It's not a formal diagnosis but describes a visible sign of significant weight loss, similar to "Ozempic face" or "Ozempic feet," caused by reduced subcutaneous fat and skin not contracting quickly enough.
Yes, most people regain a significant amount of weight after stopping Ozempic (semaglutide) because appetite and cravings return, often regaining two-thirds of lost weight within a year, but this can be mitigated by gradual tapering, sustained exercise, and a healthy diet to manage the underlying chronic nature of obesity, says this source, this source, this source, and this source.
While you can stop Ozempic "cold turkey" without dangerous withdrawal symptoms, a gradual reduction might help your body adjust more easily. Some healthcare providers recommend tapering with lower doses before stopping completely. This approach might help with the transition as your body readjusts its hormone levels.
If you've gone longer than a week or two without the medication, using the drug again can provoke serious gastrointestinal side effects. You may need help from your clinician to get safely back on track.